Stanford University School of Humanities and Sciences

Project Liberty Expands Global Alliance to Strengthen Democracy and Responsible Technology

Retrieved on: 
Wednesday, June 14, 2023
Networking hardware, Partnership, Social, Democracy, Stanford University School of Humanities and Sciences, Stanford University, Internet, Georgetown, Policy, Civic, Project Liberty, Research, Georgetown University, Silicon, Digital technology, Ethics, Humanities, Stanford Law School, McCourt, Algorithm, School, Conway Hall Ethical Society, Technology Hub, AI, Sciences Po, Project Liberty Ship, Health, Society, Stanford Institutes of Medicine Summer Research Program, Social media, Safety, Cryptocurrency, Renewable energy

NEW YORK, June 14, 2023 /PRNewswire/ -- Project Liberty today announced that Stanford University has joined Project Liberty's institute (formerly The McCourt Institute) as a founding partner, alongside Georgetown University and Sciences Po, to collaborate on advancing a more responsible approach to digital technology worldwide.

Key Points: 
  • Launched in 2021 by founder and civic entrepreneur Frank McCourt, Jr., Project Liberty is an independent, international nonprofit to advance responsible development of the internet of tomorrow, designed and governed for the common good.
  • "Project Liberty and its institute aim to foster a global network of the most innovative thinkers on technology for the common good.
  • "Tech companies have a disproportionate influence and power over our lives," said Martina Larkin, CEO of Project Liberty.
  • Working with Stanford and our other institute partners will accelerate research and the emergence of responsible technology."

Dr Carolyn Bertozzi, 2022 Nobel Prize Winner, Confirmed to Keynote at IO360º in NYC

Retrieved on: 
Thursday, December 1, 2022
Doctor of Philosophy, Science, Conference, Cancer, R, Stanford University School of Humanities and Sciences, Humanities, Patient, Nobel Prize, Nobel Prize in Chemistry, Drug development, School, Stanford University, Research, Therapy, Ecosystem, Immunity, Systems biology, Immunotherapy, Click chemistry, Nobel Prize in Physics, Pharmaceutical industry, Chemistry, MD, Radiology

NEW YORK, Dec. 1, 2022 /PRNewswire-PRWeb/ -- The Conference Forum announced Carolyn R Bertozzi, PhD, Stanford University, 2022 Nobel Prize Winner in Chemistry, as Keynote Speaker of the 9th annual Immuno-Oncology 360º (IO360º) conference, taking place February 7-10, 2023 in New York City.

Key Points: 
  • The Conference Forum announced Carolyn R Bertozzi, PhD, Stanford University, 2022 Nobel Prize Winner in Chemistry, as Keynote Speaker of the 9th annual Immuno-Oncology 360 (IO360) conference, taking place February 7-10, 2023 in New York City.
  • NEW YORK, Dec. 1, 2022 /PRNewswire-PRWeb/ -- The Conference Forum announced Carolyn R Bertozzi, PhD, Stanford University, 2022 Nobel Prize Winner in Chemistry, as Keynote Speaker of the 9th annual Immuno-Oncology 360 (IO360) conference, taking place February 7-10, 2023 in New York City.
  • In her keynote, Dr Bertozzi will share how her work in bioorthogonal and click chemistry is being applied to help advance cancer immunotherapy research.
  • "We're excited for Dr Bertozzi to share with the IO360 audience how her novel approach to chemistry advances research into cancer immunotherapies," said Kate Woda, IO360 Conference Director.

InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry

Retrieved on: 
Thursday, October 6, 2022
Technology, Biotechnology, Nanotechnology, Health, Consumer, Healthcare Reform, Public Policy, Government, Oncology, Other Science, Other Technology, Research, Science, Women, Data Management, Anne, Stanford University School of Humanities and Sciences, Humanities, Therapy, Monroe Dunaway Anderson, Glycoprotein, Nobel Prize, List of Nobel laureates, Biology, Entrepreneurship, Regents of the University of California, History, Cancer, Sugar, Science, CEO, UC, Chemistry, Protein, University of California, Davis, Decision-making, Nobel, Stanford University, Paganini Competition, School, Pharmaceutical industry, Medical device, Technology, Biotechnology, Nanotechnology, Health, Consumer, Healthcare Reform, Public Policy, Government, Oncology, Other Science, Other Technology, Research, Science, Women, Data Management

InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that its co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in chemistry.

Key Points: 
  • InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that its co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in chemistry.
  • "Dr. Carolyn Bertozzi's receipt of the Nobel Prize underscores the significant contributions she has made in shaping the future of disease screening, clinical decision-making and therapeutics, said Aldo Carrascoso, Co-Founder and CEO of InterVenn Biosciences.
  • We have leveraged Dr. Bertozzis breakthroughs to answer the fundamental questions about sugar proteins, and the Nobel Prize that she received today is validation of her important work.
  • Dr. Bertozzi is the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, and a professor of chemistry at Stanford University.